O'Shaughnessy Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

O'Shaughnessy Asset Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-329	Closed	-$7K	–	1785
2021 Q3	$7K	Hold	329	–	–	﹤0.01%	2246
2021 Q2	$7K	Hold	329	–	–	﹤0.01%	2072
2021 Q1	$6K	Hold	329	–	–	﹤0.01%	1886
2020 Q4	$6K	Buy	+329	New	+$6.08K	﹤0.01%	1633

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return

O'Shaughnessy Asset Management's HQL Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q4 2021, closing a stake of 329 shares — an estimated $7K sold.

O'Shaughnessy Asset Management first reported a position in HQL in Q4 2020 and held it in 4 quarters. The position peaked at $7K in Q3 2021. 67 funds tracked by Wall St. Rank hold HQL as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining abrdn Life Sciences Investors position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 329 abrdn Life Sciences Investors shares in Q4 2021, an estimated $7K.
O'Shaughnessy Asset Management first reported a position in abrdn Life Sciences Investors in Q4 2020 and held it in 4 quarters.
O'Shaughnessy Asset Management's abrdn Life Sciences Investors position peaked at $7K in Q3 2021.
67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.